Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Akhil Sahib
Observed name:
AKHIL SAHIB
Institution:
All India Institute of Medical Sciences
Observed institution:
All India Institute of Medical Sciences
ORCID:
0000-0002-2497-7452
Observed ORCID:
0000-0002-2497-7452
OpenAlex ID:
A5015897373
Safety and efficacy of N-acetylcysteine (NAC) as an adjunct to standard treatment in patients with acute ischemic stroke: a randomized controlled pilot trial (NACTLYS)
2024
·
Snigdha Komakula
, Rohit Bhatia
, et al.
·
Scientific Reports
·
32
PDF
Escalate: Linezolid as an add on treatment in the intensive phase of tubercular meningitis. A randomized controlled pilot trial
2023
·
Akhil Sahib
, Rohit Bhatia
, et al.
·
Tuberculosis
·
21
Linezolid As An Add On Treatment In The Intensive Phase Of Tubercular Meningitis. A Randomized Controlled Pilot Trial. (S25.004)
2023
·
AKHIL SAHIB
, ROHIT BHATIA
, et al.
·
Neurology
Escalate: Linezolid as an add on treatment in the intensive phase of tubercular meningitis - a randomized controlled trial
2021
·
Akhil Sahib
, Rohit Bhatia
·
Journal of the Neurological Sciences
Show more works
View as search
Works count:
4
Citation count:
53
H-index:
2
I10-index:
2
Year
Topic
Type